Pediatric Oncology and the Impact of Molecular

Dr. Jeffrey C. Allen, M.D. is a dad and a doctor. The experience of his own child getting sick with cancer had a profound impact on his career. He discusses the progress that’s been made in pediatric oncology and its next frontier: molecular therapy.

Jeffrey C. Allen, M.D., currently serves as Otto and Marguerite Manley and Making Headway Foundation & Endowed Professor of Pediatric Neuro-oncology at NYU Langone Medical Center. Dr. Allen’s medical specialties include Cancer, Pediatric Neurology, Neurology, Pediatrics, and Pediatric Hematology-Oncology. His medical expertise includes Pediatric Neurology, Neuro-Oncology, Brain Tumors, Pediatric Hematology/Oncology, Brain/Spinal Cord Tumors, Pediatric Neuro-Oncology, and Brain Cancer. Dr. Allen is board certified and a Diplomate of the American Board of Psychiatry and Neurology with Special Competence in Child Neurology. He received his Doctor of Medicine from Harvard University and completed his Residency in Pediatrics at Montreal Children’s Hospital.

订阅 GLG 洞见趋势月度专栏

输入您的电子邮件,接收我们的月度通讯,获取来自全球约 100 万名 GLG 专家团成员的专业洞见。